moxisylyte has been researched along with Buerger Disease in 1 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghiglino, GC | 1 |
| Viacava, A | 1 |
| Gori, A | 1 |
| Misuri, A | 1 |
| Lucertini, G | 1 |
| Pelagatti, M | 1 |
1 other study available for moxisylyte and Buerger Disease
| Article | Year |
|---|---|
[Clinical use of thymoxamine in peripheral arterial pathology].
Topics: Adult; Aged; Arterial Occlusive Diseases; Female; Humans; Leg; Leriche Syndrome; Male; Middle Aged; | 1983 |